AzTrials
AzTrials

Scapular DyskinesisNCT06202391

Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques Effect on Swimming Performance on Swimmers With Scapular Dyskinesis

A study testing Autogenic Inhibition-MET and Reciprocal Inhibition-MET protocol in people with Scapular Dyskinesis, run by Foundation University Islamabad at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Swimming can cause shoulder pain due to scapular dyskinesis. Proper scapula movement is necessary for efficient swimming strokes and to avoid injury. Studying the effects of autogenic and reciprocal inhibition muscle energy techniques on swimmers with scapular dyskinesis can lead to effective interventions and reduce… Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Scapular Dyskinesis
What is being tested?
Autogenic Inhibition-MET and Reciprocal Inhibition-MET protocol
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 sitePakistan
Study dates
30 Aug 2023to 1 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Swimmers with at least four times training per week
  • Does not have any shoulder pain or injury or operation to the shoulders
  • Positive Scapular Dyskinesis diagnosis test
  • Freestyle (also known as a front crawl) swimming stroke

Who cannot join

  • Shoulder pain in the last six months
  • History of shoulder surgery or fracture within the last six months
  • Frequent practice of physical activity in any other sport
  • Negative result of the Scapular Dyskinesis test
  • Other swimming strokes

Trial locations and contacts

1 site in 1 country.

Ayesha Sameen, MS-MSKPT* contact

03394016858

ayessha.sameen@gmail.com

Pakistan1 site, 1 recruiting
  • Foundation University College of Physical Therapy

    Rawalpindi, Punjab Province, 46000

    Sana Bashir, DPT, MS-CPPT,PHD*, 03218529475, Sana.bashir65@gmail.com

    Recruiting

Other trials in Pakistan

About this study

Swimming can cause shoulder pain due to scapular dyskinesis. Proper scapula movement is necessary for efficient swimming strokes and to avoid injury. Studying the effects of autogenic and reciprocal inhibition muscle energy techniques on swimmers with scapular dyskinesis can lead to effective interventions and reduce shoulder injuries

Read the detailed description

Efficient swimming strokes require proper positioning of the scapula. Scapular dyskinesis (SD) is a condition where normal scapular kinematics are altered due to injury or changes in muscle activation. Swimmers, who are considered overhead athletes, have risk of developing SD. Even individuals who do not experience symptoms can have SD, and it may lead to future shoulder injuries. Early diagnosis and treatment of this condition can prevent it from progressing and minimize the risk of injury. Additionally, using autogenic and reciprocal inhibition muscle energy techniques can enhance the activation of the appropriate muscles responsible for scapular movement, which can lead to more effective interventions, improved swimming performance, and reduced injury risk. he intervention protocol (Muscle energy techniques to the upper fibers of the Trapezius, Levator Scapulae, Pectoralis Major, Latissimus Dorsi) will be conducted for 8-14 minutes over 3 weeks with 12 sessions/4 times a week. Outcomes measure will be assessed after the intervention period and data will be analyzed.

Being tested
Autogenic Inhibition-MET, Reciprocal Inhibition-MET protocol
Keywords
Scapular Dyskinesis, Autogenic inhibition, Reciprocal inhibition, Muscle energy Technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autogenic Inhibition-METProcedure or surgery

    Autogenic Inhibition-MET protocol: 3-5 repetitions of post isometric relaxation (PIR) (30- 50% isometric contraction of the muscle to be stretched for 5-10 seconds, followed by rest period of 5 seconds and then a stretch of 20-30 seconds' hold. A total of 12 sessions, four times a week, for three consecutive weeks.

  • Reciprocal Inhibition-MET protocolProcedure or surgery

    Reciprocal Inhibition-MET protocol: 3-5 repetitions of Reciprocal Inhibition (RI) MET (30- 50% isometric contraction of the muscle opposite to the muscle to be stretched for 5-10 seconds, followed by rest period of 5 seconds and then a stretch of 20-30 seconds' hold A total of 12 sessions, four times a week, for three consecutive weeks

Study groups in NCT06202391
Study groupRoleWhat they receive
Group A (Autogenic inhibition muscle energy technique)Experimental12 sessions will be conducted over a period of 4 weeks with 3 days per week Frequency: 12 sessions, four times a week for 3 consecutive weeks Time duration: apporx. 8 to 10 minutes
Receives: Procedure: Autogenic Inhibition-MET
Group B (Reciprocal inhibition muscle energy technique)Experimental12 sessions will be conducted over a period of 3 weeks with 4 days per week Frequency: 12 sessions, four times a week for 3 consecutive weeks Time duration: apporx. 8 to 10 minutes
Receives: Procedure: Reciprocal Inhibition-MET protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stroke velocity

    Stroke velocity will be assessed using KINOVEA

    Measured: 3 weeks

  2. Stroke rate

    Stroke rate will be assessed using KINOVEA

    Measured: 3 weeks

  3. stroke length

    Stroke length will be assessed using KINOVEA

    Measured: 3 weeks

  4. Total strokes

    Total strokes will be assessed using KINOVEA

    Measured: 03 Week

  5. Stroke time

    Stroke time will be assessed using KINOVEA

    Measured: 03 Week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2024
  2. Study start30 Aug 2023
  3. Primary completion15 Jan 2024 (estimated)
  4. Study completion1 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06202391
Sponsor's protocol ID
FUI/CTR/2023/27
Status last verified
Jan 2024
First submitted
1 Jan 2024
Last updated
11 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Autogenic Inhibition-MET and Reciprocal Inhibition-MET protocol in people with Scapular Dyskinesis, run by Foundation University Islamabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ayesha Sameen, MS-MSKPT* (03394016858, ayessha.sameen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stroke velocity (time frame: 3 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in